Variables | QLQ-C30-Functional scales | |||
---|---|---|---|---|
S.E | Sig | OR | 95% CI | |
Age | 0.94 | 0.135 | 0.25 | 0.04–1.55 |
Comorbidity | 0.44 | 0.355 | 0.67 | 0.28–1.58 |
Medications (ref. conventional therapy) | ||||
Hormonal therapy | 0.53 | 0.01** | 3.74 | 1.32–10.63 |
Targeted therapy | 1.13 | 0.04* | 10.2 | 1.11–93.88 |
Stage of tumor (ref. stage 1) | ||||
Stage 2 | 0.73 | 0.13 | 0.33 | 0.08–1.39 |
Stage 3 | 0.41 | 0.26 | 0.64 | 0.29–1.41 |
Cycle of chemotherapy | 0.41 | 0.36 | 0.69 | 0.31–1.54 |
QLQ-C30-Symptom scales | ||||
Age | 1.01 | 0.516 | 1.921 | 0.27–13.79 |
Comorbidity | 0.46 | 0.863 | 0.924 | 0.38–2.26 |
Medications (ref. conventional therapy) | ||||
Hormonal therapy | 0.67 | 0.000*** | 0.07 | 0.02–0.29 |
Targeted therapy | 0.86 | 0.08 | 0.22 | 0.04–1.25 |
Stage of tumor (ref. stage 1) | ||||
Stage 2 | 0.85 | 0.14 | 3.52 | 0.67–18.61 |
Stage 3 | 0.39 | 0.76 | 1.13 | 0.53–2.42 |
Cycle of chemotherapy | 0.40 | 0.87 | 0.94 | 0.43–2.05 |